Observe Carefully (one)pentobarbital will lessen the level or influence of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Observe sufferers currently on buprenorphine subdermal implant who involve recently-initiated treatment with CYP3A4 inducer for symptoms and signs of withd